Cytostatic drugs in the treatment of severe vasculitides. Indications, results and risks.
The indications for cytostatic drugs in the treatment of cerebral vasculitis are discussed as well as the possible risks of long-term immunosuppressive therapy.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D013700:Giant Cell Arteritis / Q000188:drug therapy; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D010488:Polyarteritis Nodosa / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D014657:Vasculitis / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone